ArticleFrontiers in immunology2022

Maintenance therapy of low-dose nivolumab, S-1, and leucovorin in metastatic pancreatic adenocarcinoma with a germline mutation of

Shang-Hsuan Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.